- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.08. | The Healthcare Leaders Driving Change Need to Get Better at Explaining It | ||
| 05.08. | QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll | ||
| 05.08. | How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians | ||
| 04.08. | Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents | ||
| 04.08. | Health Tech Promised Simplicity - Why Does It Feel Like More Work? | ||
| 04.08. | From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS | ||
| 04.08. | The Trust Gap in Digital Health and AI Starts With Design - Here's How to Close It | ||
| 04.08. | HHS Is Reviving Its 340B Rebate Push - And Providers Are None Too Pleased | ||
| 04.08. | Report: Telehealth Uptake Is Lagging in Rural Areas | ||
| 03.08. | Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company | ||
| 03.08. | From Ethics to Trust: Strategic Guardrails for Safe, Secure, Effective AI in Healthcare | ||
| 03.08. | Beyond Adoption: The Habits Shaping Digital Health | ||
| 03.08. | 'We're Not Going to Be Bullied': Sentara Digs in on Anthem Contract Fight | ||
| 03.08. | Apnimed's IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug | ||
| 02.08. | 4 Notable Health Tech Funding Announcements in July | ||
| 02.08. | The Next Phase of Value-Based Care: Why Specialty-Led Models Will Define the Future of Healthcare | ||
| 02.08. | Hope Is Not a Soft Concept, It's a Strategic Imperative in Cancer Innovation | ||
| 31.07. | Startup to Acquisition in 2 Years: Grove AI's Journey to Transform Clinical Trials | ||
| 31.07. | Daffodil Health Launches No Surprises Act Dispute Management Solution | ||
| 31.07. | The Battles We Face: ADHD From A Patient Perspective, And What Providers Should Know | ||
| 31.07. | Three Ways Distressed Healthcare Must Evolve | ||
| 31.07. | Why General Catalyst Is Betting $450M on Function Health's Preventive Care Push | ||
| 31.07. | We Are Rats; If Pharma Could Be Brave … And Other Bullseye POVs You Won't Hear at Other Events | ||
| 30.07. | Why Hims & Hers Is Embroiled in Yet Another Controversy, This Time with the FTC | ||
| 30.07. | J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.